Changing the Game in Life Sciences, presented by SAP

By Bonnie D. GrahamNews Science Social Sciences Technology Business News

Changing the Game in Life Sciences, presented by SAP episodes

November 16, 2017 Encore: Reimagining Business Models in Life Sciences
The buzz: “All verticals are experiencing an explosion of data–but in healthcare and especially the life sciences field, the scale of this explosion is staggering” (Rahul Joshi).
58 min
November 02, 2017 Blockchain Meets Life Sciences: Now What?
The buzz: “According to Deloitte, the healthcare industry is planning the most aggressive deployments of blockchain, with 35 percent of health and life sciences planning to deploy by 2018” (Vala Afshar).
57 min
October 19, 2017 Outcome-Based Pricing: Cure for An Ailing Healthcare Industry?
The buzz: “One in four health plans now have ‘at least one outcomes-based contract’ with a drug maker, an Avalere Health survey showed.
56 min
October 05, 2017 Reimagining Business Models in Life Sciences
The buzz: “All verticals are experiencing an explosion of data–but in healthcare and especially the life sciences field, the scale of this explosion is staggering” (Rahul Joshi).
58 min
September 21, 2017 How the Digital Economy Is Changing Life Sciences
The buzz: “Imagine knowing whether your DNA encodes a risk for migraines even before a headache strikes” (Yale Journal of Biology and Medicine).
58 min

About Changing the Game in Life Sciences, presented by SAP

From the publisher's feed

By 2025, the global life sciences market will have changed dramatically from the industry we know today. Patients will be more accountable for their care and have greater access to their personal health information. Patients and payers will demand personalized treatments with superior outcomes, but cost-effectively. Technology will allow patients to use smart devices to monitor their health in real time while collaborating with their physicians from home. Patient outcomes will be continually monitored to identify patient populations that may have an identical genetic predisposition to a treatment, while providing early detection of any adverse events. Patients, physicians, providers, and producers will collaborate tightly within a treatment protocol to ensure optimal outcomes at reduced costs.